Average Co-Inventor Count = 8.76
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genentech, Inc. (13 from 3,222 patents)
2. Medical Research Council Technology (1 from 3 patents)
3. F. Hoffmann-la Roche Ag (168 patents)
4. F. Hoffmann-la Roche Sa (0 patent)
13 patents:
1. 11236046 - Substituted heterocyclic sulfonamide compounds useful as TRPA1 modulators
2. 11129832 - Biheteroaryl compounds and uses thereof
3. 10913742 - Oxadiazolones as transient receptor potential channel inhibitors
4. 10711004 - Oxadiazole transient receptor potential channel inhibitors
5. 10597383 - Bicyclic proline compounds
6. 10179782 - Substituted sulfonamide compounds
7. 10131675 - Tricyclic DLK inhibitors and uses thereof
8. 10010549 - Biheteroaryl compounds and uses thereof
9. 9145402 - Aminopyrimidine derivatives as LRRK2 modulators
10. 8809331 - Aminopyrimidine derivatives as LRRK2 modulators
11. 8802674 - Aminopyrimidine derivatives as LRRK2 modulators
12. 8569281 - Compounds and their administration for treating a neurodegenerative disease as well as a method for identifying a compound capable of inhibiting a kinase, such as LRRK
13. 8354420 - Aminopyrimidine derivatives as LRRK2 inhibitors